Several treatments used in IBD exert their anti-inflammatory action via epigenetic modifications, such as 5ASA [258,259], anti-TNF [125,127,260,261,262,263,264], exclusive enteral nutrition [265] and mesenchymal stem cells [266,267]. The gene discussed is TNF; the disease is inflammatory bowel disease.